 cyclosporin plaque-typ psoriasi result multidos double-blind trial background sever plaque-typ psoriasi cyclosporin compar evalu variou dosag efficaci side effect method double-blind trial patient sever psoriasi mg cyclosporin kilogram bodi weight day placebo consist vehicl drug week dose safeti efficaci result psoriasi dose-depend fashion week fixed-dos therapi percent patient mg cyclosporin day clear clear psoriasi group signific improv group vehicl none patient clear clear patient mg kilogram like dosag adjust side effect lack efficaci glomerular filtrat rate subgroup patient cyclosporin median percent dose cyclosporin advers effect systol blood pressur glomerular filtrat rate serum level creatinin uric acid bilirubin cholesterol delayed-typ hypersensit reaction skin-test antigen cyclosporin administr cyclosporin concentr skin conclus cyclosporin therapi rapid thorough clear psoriasi initi dose mg day appropri safeti cyclosporin long-term treatment psoriasi